期刊文献+

EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR GENE ENCODED VACCINIA VIRUS VECTOR ON MURINE PULMONARY METASTATIC MELANOMA

EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR GENE ENCODED VACCINIA VIRUS VECTOR ON MURINE PULMONARYMETASTATIC MELANOMA
暂未订购
导出
摘要 A recombinant vaccinia virus expressing murine granulocyte-macrophage colony-stimulating factor (VVGM-CSF) was tested for its antitumor activity.Murine pulmonary metastasis was established by injecting 20×10~5 B16F10 melanoma cells into the tail vein of C57BL/6 mice. Three days after B16F10 inoculation,WGM-CSF or VVTK, a thymidine kinase gene deficient control vaccinia virus, were injected intraperitoneally twice weekly for 2 weeks. Two weeks later, the mice were sacrificed and pulmonary metastasis fool counted.The results demonstrated that VVGM-CSF treatment significantly decreased the number of pulmonary metastasis and prolonged the survival time of tumorbearing mice. Cytotoxic and phagocytic activities of the peritoncal macrophages were found to be markedly elevated in mice treated with WGM-CSF. Nitric oxide released from the macrophages was also found to be increased. These data, together with our other results,strongly demonstrated that continuous secretion of GMCSF and activation of macrophages might pal-tially explain the therapeutic effects of VVGM-CSF on murine pulmonary metastasis. A recombinant vaccinia virus expressing murine granulocyte-macrophage colony-stimulating factor (VVGM-CSF) was tested for its antitumor activity.Murine pulmonary metastasis was established by injecting 20×10~5 B16F10 melanoma cells into the tail vein of C57BL/6 mice. Three days after B16F10 inoculation,WGM-CSF or VVTK, a thymidine kinase gene deficient control vaccinia virus, were injected intraperitoneally twice weekly for 2 weeks. Two weeks later, the mice were sacrificed and pulmonary metastasis fool counted.The results demonstrated that VVGM-CSF treatment significantly decreased the number of pulmonary metastasis and prolonged the survival time of tumorbearing mice. Cytotoxic and phagocytic activities of the peritoncal macrophages were found to be markedly elevated in mice treated with WGM-CSF. Nitric oxide released from the macrophages was also found to be increased. These data, together with our other results,strongly demonstrated that continuous secretion of GMCSF and activation of macrophages might pal-tially explain the therapeutic effects of VVGM-CSF on murine pulmonary metastasis.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1997年第1期16-20,共5页 中国癌症研究(英文版)
关键词 Vaccinia virus Gene therapy Melanoma Granulocyte-macrophage colony-stimulating factor Vaccinia virus, Gene therapy, Melanoma,Granulocyte-macrophage colony-stimulating factor
  • 相关文献

参考文献8

  • 1Dian Wen Ju,Xuetao Cao,Bruce Acres.Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus[J]. Journal of Cancer Research and Clinical Oncology . 1996 (12)
  • 2Muthukumaran Sivanandham,Stephen D. Scoggin,Nobuyuki Tanaka,Marc K. Wallack.Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model[J]. Cancer Immunology Immunotherapy . 1994 (4)
  • 3Pedro J. Arroyo,Jerry A. Bash,Marc K. Wallack.Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis model[J]. Cancer Immunology Immunotherapy . 1990 (5)
  • 4Ju DW,Cao X,Acres B.Intratumoral injection ofGM-CSF-gene encoded recombinant vaccinia viruselicits potent amitumor response in a murinemelanoma model. Cancer Gene Therapy . 1997
  • 5Van de Loosdrecht AA,Nerinie E,Ossenkoppele GJ,et al.Cell mediated cytotoxicity against U937 cellsby human monocytes and macrophages in a modifiedcolomatric Mad assay. Journal of Immunological Methods . 1991
  • 6Whitman ED,Tsung K,Paxson J,et al.In vitro andin vivo kinetics of recombinant vaccinia viruscancergene therapy. Journal of Surgery . 1994
  • 7Elkins KL,EnniSt DL,Winegar RT,et al.Ic vinodelivery of interleukin.-4 by a recombinant vacciniavirus preveflts tllmor developmam in mice. Human Gene Therapy . 1994
  • 8Bash JA.Recombinant vaccinia virus interleukin-2’ infected tUmor cell vaccines in immunotherapy ofmurine colon adenocarcinoma. Journal of Immunotherapy . 1993

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部